Published in Minerva Anestesiol on June 01, 1968
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med (1973) 5.53
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med (1973) 4.99
Periodontal dressing may influence the clinical outcome of non-surgical periodontal treatment: a split-mouth study. Int J Dent Hyg (2011) 1.44
Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother (2001) 1.14
A critique of the World Resources Institute's report "Pesticides and the immune system: the public health risks". Environ Health Perspect (1998) 0.85
Association between genetic risk score and periodontitis onset and progression: a pilot study. Arch Oral Biol (2011) 0.83
Thiophene systems. 9. Thienopyrimidinedione derivatives as potential antihypertensive agents. J Med Chem (1988) 0.81
Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders. J Invest Dermatol (1998) 0.80
[Local anesthetics and antalgic therapy]. Minerva Anestesiol (1980) 0.78
[The contribution of schermography in determination of thoracic diseases. (Investigations done in Italy in 1962)]. Ann Sanita Pubblica (1966) 0.75
[Role of the vasomotor nervous system in the regulation of pulmonary circulation]. Minerva Anestesiol (1969) 0.75
[Tissue respiratory changes induced by intra-arterial introduction of microspheres. Preliminary experimental data]. Minerva Med (1968) 0.75
[Muscle relaxing properties of diazepam]. Minerva Anestesiol (1969) 0.75
[Our experience with a new synthetic analgesic preparation: WIN 20,228 (pentazocine)]. Minerva Anestesiol (1969) 0.75
[Our experience with CI-581]. Minerva Anestesiol (1969) 0.75
[High subarachnoid (C5-C6) anesthetic block as a complication of stellate ganglion infiltration. Description of a case]. Minerva Anestesiol (1968) 0.75
[The use of Citanest-Octapressin]. Minerva Anestesiol (1968) 0.75
[Controlled hypotension and muscular activity]. Minerva Anestesiol (1968) 0.75
[Acute toxicity of LAC-43 and other local anesthetics with octapressine and its relation to their solution with adrenaline]. Minerva Anestesiol (1968) 0.75
[Penthrane analgesia with analgizer in obstetrics]. Minerva Anestesiol (1973) 0.75
[Complications of peridural anesthesia]. Minerva Anestesiol (1967) 0.75
[Cardio-respiratory findings and clinico-anesthiological notes on the association of levomepromazine and pethidine]. Minerva Med (1967) 0.75
[Effect of diazepam on intestinal motility. Experimental study]. Minerva Anestesiol (1968) 0.75
[Problems of fibrinolysis in extracorporeal circulation. Clinical and experimental research]. Minerva Anestesiol (1966) 0.75
[Current status of cryotherapy in oncology]. Minerva Med (1970) 0.75
The electrical treatment of paroxysmal ventricular tachycardia. Acta Cardiol (1968) 0.75
[Changes in the hematic pseudocholinesterase concentration after administration of LAC-43 (bupivacaine or Marcaine). Experimental study]. Minerva Anestesiol (1968) 0.75
[Anestesiologic problems in porphyria patients]. Minerva Anestesiol (1968) 0.75
[The treatment of postoperative respiratory insufficiency in acquired heart diseases]. Minerva Med (1968) 0.75
[Antiarrhythmic activity of a new local anesthetic (F.I. 6655)]. Minerva Anestesiol (1969) 0.75
[Muscular activity in the course of anesthesia]. Minerva Anestesiol (1967) 0.75
[Plasil in the prevention and treatment of postoperative digestive complications in children]. Minerva Anestesiol (1968) 0.75
[Clinical study of the changes in gastric secretion in children in relation to anesthesia and to the surgical operation]. Minerva Anestesiol (1967) 0.75
CODE 75: Operative protocols and a case report in preventive dental care in a department of neurorehabilitation for acquired cerebral lesions. Int J Dent Hyg (2010) 0.75
[Changes in the arterioveous O2 gradient following to intravenous administration of methyldiazepinone]. Minerva Anestesiol (1969) 0.75
[Short-term narcosis and laryngospasm]. Minerva Anestesiol (1968) 0.75
[Clinical notes on a new synthetic psycholeptic drug in preanesthetic medication]. Minerva Anestesiol (1966) 0.75
[On a rare accident during ventilation with Carlens' tube]. Minerva Anestesiol (1969) 0.75
[On an association of amino acids and carbohydrates in the oncological field. (Clinico-therapeutic note)]. Cancro (1967) 0.75
[Some photographic aspects of the microcirculatory changes induced by the vasoconstrictors adrenaline and octapressin]. Minerva Anestesiol (1968) 0.75
[Reactions induced in the body by loco-regional administration of radioisotopes]. Minerva Med (1967) 0.75
[On some cases of respiratory insufficiency after open heart surgery]. Minerva Anestesiol (1965) 0.75
[Intravenous levopromazine in anesthesiologico-surgical practice]. Minerva Anestesiol (1967) 0.75
[Behavior of fibrinolytic activity of the blood in the pleural cavity during and after pulmonary and cardiac surgical operations]. Minerva Anestesiol (1966) 0.75
[The local anesthetic action of Bayer 1420. Experimental study and clinical report on 32 patients]. Minerva Anestesiol (1967) 0.75
[On the use of methyldiazepinone in high doses for preinduction anesthetics in oncological surgery]. Minerva Anestesiol (1967) 0.75
[Atypical neurovascular pains in the head. Relation between sphygmographic charges caused by anesthetic block and the antalgic effect]. Minerva Anestesiol (1967) 0.75
[Cardiac and respiratory evaluations and clinical-anesthesiologic notes on the combination of levomepromazine and petidine]. Minerva Anestesiol (1967) 0.75
[Diallyl-nortoxyferin and intestinal persistalsis]. Minerva Anestesiol (1969) 0.75
[Evaluation of the time of latency and duration of local anesthetics by periarterial block. Sphygmographic study]. Minerva Anestesiol (1967) 0.75
[Problems of water and electrolyte therapy in cardiocirculatory intensive care. Role of the measurement of central venous pressure and of wedge pulmonary pressure]. Minerva Anestesiol (1976) 0.75
Increased vasodilator responsiveness to BRL 34915 in spontaneously hypertensive versus normotensive rats: contrast with nifedipine. Proc Soc Exp Biol Med (1989) 0.75
FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act. J Toxicol Environ Health (1997) 0.75
Subchronic and chronic toxicological investigations on metiram: the lack of a carcinogenic response in rodents. Toxicol Sci (2000) 0.75
[Effect of CI-581 on ocular tone in rabbits]. Minerva Anestesiol (1969) 0.75
[On a rare case of sodium thiopentone incompatibility]. Minerva Anestesiol (1966) 0.75
[Normalization of the gastrointestinal function after pediatric surgery]. Minerva Anestesiol (1968) 0.75
[Treatment of the diabetic patient undergoing surgical treatment (application of the 6-hour method)]. Minerva Anestesiol (1968) 0.75
[On the experimentation with a new water soluble benzodiazepine derivative SAS 538]. Minerva Anestesiol (1969) 0.75
[Preliminary clinical observations on the use of LAC-43 in segmentary peridural anesthesia]. Minerva Anestesiol (1968) 0.75
[Behavior of the blood sugar level during anesthesia with methoxyflurane]. Minerva Anestesiol (1967) 0.75
[Striated muscle fibers and CI-581]. Minerva Anestesiol (1969) 0.75
[Potential preanesthesia. Clinico-experimental report on the use of a new pharmacologic association (S.A.S.)]. Minerva Anestesiol (1968) 0.75